96762 ⎘
Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
COMPOSITIONS FOR TREATING EPITHELIAL BARRIER FUNCTION DISORDERS
#2Immunogenic composition
#3Muramyl peptide derivatives
#4Immunogenic composition
#5Muramyl peptide derivative compound, synthesis and uses thereof
#6Skin treatment devices and methods with pre-stressed configurations
#7Synthetic N-acetyl-muramic acid derivatives and uses thereof
#8Skin treatment devices and methods with pre-stressed configurations
#9Apolipoprotein AIV as an antidiabetic peptide
#10Alpha-1 antitrypsin variant, preparation method thereof and use thereof
#11Cell-based detection of APF through its interaction with CKAP4 for diagnosis of interstitial cystitis
#12Apolipoprotein AIV as an antidiabetic peptide
#13Skin treatment devices and methods with pre-stressed configurations
#14Treatment devices and methods with extending elements
#15Skin treatment devices and methods with pre-stressed configurations
#16Cell-based detection of APF through its interaction with CKAP4 for diagnosis of interstitial cystitis
#17Compounds
#18Normuramyl glycopeptide compounds
#19TRIAZOLE-BASED AMINOGLYCOSIDE-PEPTIDE CONJUGATES AND METHODS OF USE
#20Targeted delivery to legumain-expressing cells
#21Derivatives of APF and methods of use
#22Method for producing peptide thioester
#23Methods for the treatment or prevention of scars and/or keloids
#24Antiproliferative factor and methods of use
#25Tumor-activated prodrug compounds and treatment
#26Method for modulating Nod1 activity, use of a MTP related molecule for modulating Nod1 activity, and therapeutic applications thereof
#27Antiproliferative factor and methods of use
#28Glycosulfopeptide inhibitors of leukocyte rolling and methods of use thereof
#29Synthetic polysaccharide antigens for immunological intervention in disease
#30Biodegradable glucosamine-muramyl peptides for apoptosis modulation
#31Method for modulating Nod1 activity, use of a MTP related molecule for modulating Nod1 activity, and therapeutic applications thereof
#32Protein-binding doxorubicin peptide derivatives
#33Tumor-activated prodrug compounds and treatment
#34Targeted delivery to legumain-expressing cells
#35Modulation of interaction between Nod1 and Gram-negative bacteria by Nod1 response to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island (cagPAI)
#36Glycopeptide and peptide having a taste imparting function, and method of imparting the taste to foods
#37Glycosulfopeptide inhibitors of leukocyte rolling and methods of use thereof
#38Agents and methods for promoting bone growth
#39Conjugates comprising cancer cell specific ligands, a sugar and diagnostic agents and uses thereof
#40Novel antiproliferative factor and methods of use